ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Agios Pharmaceuticals, Inc. ?
1
Poor Management Efficiency with a low ROE of 9.08%
- The company has been able to generate a Return on Equity (avg) of 9.08% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -26.13% and Operating profit at -7.55% over the last 5 years
3
The company has declared negative results in Mar'2025 after 2 consecutive positive quarters
- OPERATING CASH FLOW(Y) Lowest at USD -406 MM
- INVENTORY TURNOVER RATIO(HY) Lowest at 0.37 times
- OPERATING PROFIT(Q) Lowest at USD -125.8 MM
4
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -50.57%, its profits have risen by 288.9% ; the PEG ratio of the company is 0
5
Below par performance in long term as well as near term
- Along with generating -50.57% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Agios Pharmaceuticals, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Agios Pharmaceuticals, Inc.
-53.43%
-0.54
74.37%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-26.13%
EBIT Growth (5y)
-7.55%
EBIT to Interest (avg)
-324.10
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.60
Sales to Capital Employed (avg)
0.03
Tax Ratio
6.23%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
9.08%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
1.73
EV to EBIT
-3.76
EV to EBITDA
-3.81
EV to Capital Employed
2.80
EV to Sales
44.67
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
-74.58%
ROE (Latest)
45.41%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend9What is working for the Company
ROCE(HY)
Highest at 64.05%
RAW MATERIAL COST(Y)
Fallen by -19.11% (YoY
NET SALES(Q)
Highest at USD 12.46 MM
OPERATING PROFIT MARGIN(Q)
Highest at -1,010.01 %
-15What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -406 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.37 times
OPERATING PROFIT(Q)
Lowest at USD -125.8 MM
PRE-TAX PROFIT(Q)
Lowest at USD -112.02 MM
NET PROFIT(Q)
Lowest at USD -112.02 MM
EPS(Q)
Lowest at USD -1.93
Here's what is working for Agios Pharmaceuticals, Inc.
Net Sales
At USD 12.46 MM has Grown at 34.52%
over average net sales of the previous four periods of USD 9.26 MMMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Net Sales
Highest at USD 12.46 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Operating Profit Margin
Highest at -1,010.01 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Raw Material Cost
Fallen by -19.11% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Agios Pharmaceuticals, Inc.
Pre-Tax Profit
At USD -112.02 MM has Fallen at -163.09%
over average net sales of the previous four periods of USD 177.56 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -112.02 MM has Fallen at -167.28%
over average net sales of the previous four periods of USD 166.5 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Cash Flow
Lowest at USD -406 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Inventory Turnover Ratio
Lowest at 0.37 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Operating Profit
Lowest at USD -125.8 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -112.02 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -112.02 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD -1.93
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
